Cequent is a developer of RNAi-based therapeutics.
An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases " from inflammatory diseases to cancer " based on the company™s proprietary technology, TransKingdom RNA interference (tkRNAi). Cequent™s first products, now in pre-clinical development, are drug candidates targeting colon-cancer prevention and inflammatory bowel disease. The company designed its powerful tkRNAi technology to deactivate specific disease-causing genes safely and effectively, using non-pathogenic bacteria as an engine to produce and deliver RNAi directly into cells. It is based on ground-breaking scientific research originating at the Institut Pasteur (Paris, France) and at the Beth Israel Deaconess Medical Center/Harvard Medical School. A privately held company based in Cambridge, Massachusetts, Cequent was established in 2006. In July 2010, Cequent Pharmaceuticals was acquired by Marina Biotech, Inc (formerly MDRNA, Inc) for $46M.
The numerical value of cequent pharmaceuticals in Chaldean Numerology is: 7
The numerical value of cequent pharmaceuticals in Pythagorean Numerology is: 1
Images & Illustrations of cequent pharmaceuticals
Find a translation for the cequent pharmaceuticals definition in other languages:
Select another language:
Discuss these cequent pharmaceuticals definitions with the community:
Word of the Day
Would you like us to send you a FREE new word definition delivered to your inbox daily?
Use the citation below to add this definition to your bibliography:
"cequent pharmaceuticals." Definitions.net. STANDS4 LLC, 2017. Web. 21 Oct. 2017. <http://www.definitions.net/definition/cequent pharmaceuticals>.